Free lookups: 2/3 Unlock Pro
Clinical reference Find a medicine
Ctrl K
2 of 3 free lookups remaining Upgrade
New search Medicine profile Ibuprofen

Clinical medicine profile

Ibuprofen

Nonsteroidal Anti-inflammatory Drug [EPC]

OTC
Evidence state Source-linked Review date not recorded
Route
ORAL / TOPICAL / RECTAL / IM (agent-dependent)
Schedule
OTC
ATC
Not assigned
PPB status
registered
Patient advice Check interactions
01 Risk first

Safety essentials

The information most likely to change a prescribing or dispensing decision.

Contraindications

  • Active peptic ulcer / GI bleeding.
  • Severe heart failure.
  • NSAID-exacerbated respiratory disease (aspirin-sensitive asthma) for non-selective agents.
  • Third trimester pregnancy (ductus arteriosus, oligohydramnios — class warning).
  • Severe renal impairment for many agents.
  • Hypersensitivity to NSAIDs.

Precautions

  • Warnings Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin.
  • Symptoms may include: rash facial swelling asthma (wheezing) hives skin reddening shock blisters If an allergic reaction occurs, stop use and seek medical help right away.
  • Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding.
  • The chance is higher if you: take more or for a longer time than directed take a blood thinning (anticoagulant) or steroid drug have had stomach ulcers or bleeding problems have 3 or more alcoholic drinks every day while using this product are age 60 or older take other drugs containing prescription or nonprescription NSAIDs [aspirin, ibuprofen, naproxen, or others] Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke.
  • These can be fatal.
  • The risk is higher if you use more than directed or for longer than directed.
  • Do not use if you have ever had an allergic reaction to any other pain reliever/fever reducer right before or after heart surgery Ask a doctor before use if stomach bleeding warning applies to you you have a history of stomach problems, such as heartburn you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke you are taking a diuretic you have problems or serious side effects from taking pain relievers or fever reducers Ask a doctor or pharmacist before use if you are under a doctor's care for any serious condition taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin taking any other drug When using this product take with food or milk if stomach upset occurs Stop use and ask a doctor if you experience any of the following signs of stomach bleeding: feel faint have bloody or black stools vomit blood have stomach pain that does not get better you have symptoms of heart problems or stroke: chest pain slurred speech trouble breathing leg swelling weakness in one part or side of body pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days redness or swelling is present in the painful area any new symptoms appear If pregnant or breast-feeding, ask a health professional before use.
  • It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
  • Keep out of reach of children.
  • In case of overdose, get medical help or contact a Poison Control Center right away.
02 Point of care

Dosing matrix

Population and organ-function guidance, shown together for faster comparison.

Adult

Directions do not take more than directed the smallest effective dose should be used adults and children 12 years and over: take 1 tablet every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 tablet, 2 tablets may be used do not exceed 6 tablets in 24 hours, unless directed by a doctor children under 12 years: ask a doctor

Paediatric

5–10 mg/kg/dose every 6–8 hours (max single dose limits apply); avoid if <3 months or dehydrated without advice.

Renal

Avoid in advanced CKD / volume depletion; can precipitate AKI.

  • CrCl 60–120: Usual short-course dosing if euvolemic.
  • CrCl 30–59: Avoid if possible; short lowest dose only with monitoring.
  • CrCl 0–29: Avoid systemic ibuprofen.
Hepatic

Avoid in severe hepatic disease.

03 Clinical use

Use, effects & interactions

Indications

  • Uses temporarily relieves minor aches and pains due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis temporarily reduces fever Clinical selection for Ibuprofen should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC.
  • Class context: Nonsteroidal Anti-inflammatory Drug [EPC].
  • Confirm site-specific dose, duration and monitoring before prescribing.

Adverse effects

  • Dyspepsia, nausea, fluid retention, raised BP.
  • Serious: peptic ulcer/bleed, AKI, heart failure exacerbation, severe skin reactions, bronchospasm, hepatitis (rare).
  • Risk-stratify GI and CV before prescribing.
  • Prefer topical NSAIDs for local MSK pain when adequate.
  • Review after short courses.
  • Educate on black stools/haematemesis red flags.
04 Pharmacology

Mechanism & disposition

Inhibitors of cyclo-oxygenase [COX-1 and COX-2] enzyme that catalyzes the conversion of arachidonic acid to PGH2.

Inhibit COX↓ ProstaglandinsAnalgesia / anti-inflammatory
Read complete mechanism

Inhibitors of cyclo-oxygenase [COX-1 and COX-2] enzyme that catalyzes the conversion of arachidonic acid to PGH2. NSAIDs inhibit cyclo-oxygenase (COX-1 and/or COX-2), reducing prostaglandin and thromboxane synthesis. This yields analgesic, antipyretic and anti-inflammatory effects. COX-1 inhibition drives many GI and platelet adverse effects; COX-2 selective agents spare some GI risk but retain CV warnings.

Onset

30–60 minutes

Duration

6–8 hours

Route

ORAL / TOPICAL / RECTAL / IM (agent-dependent)

Elimination

of metabolites. Half-lives vary widely (ibuprofen short; naproxen longer; oxicams long).

05 Special populations

Pregnancy, lactation & diet

Pregnancy

Avoid in third trimester. Earlier pregnancy: use only if needed; prefer paracetamol first-line.

Lactation

Short-course ibuprofen generally acceptable; avoid chronic high-dose/long half-life agents when possible.

06 Kenya market

Brands & loaded prices

FromKES 59
MedianKES 59
Listings13
BrandManufacturerPackObserved price
Brufen RADIANCE PHARMACEUTICALS LTD Film-Coated Tablet 400mg Unavailable
Brufen 400mg BAYER EAST AFRICA LTD Film-Coated Tablet 400mg Unavailable
CapsifenacGel Afya Index / Retail Reference gel 1% 20gm KES 500.00afya_index_book
Dawafen MACLEODS PHARMACEUTICALS LTD Film-Coated Tablet 400mg Unavailable
Dawafen 400mg MEDIVET PRODUCTS LTD Film-Coated Tablet 400mg Unavailable
Ibucos SURGIPHARM LTD Film-Coated Tablet 400mg Unavailable
Ibucos 400mg LABORATORY & ALLIED LTD Film-Coated Tablet 400mg Unavailable
IBUCOT TABLETS ELYS CHEMICAL INDUSTRIES LTD Film-Coated Tablet Unavailable
Ibugesic DAWA LIMITED Film-Coated Tablet 400mg Unavailable
Ibugesic 400mg ELYS CHEMICAL INDUSTRIES LTD Film-Coated Tablet 400mg Unavailable
IBUJECT Solution for Injection Tasa Pharma Ltd Solution For Infusion Unavailable
IBUPROFEN DAIMA BIASHARA / Wholesale Import CAPS 200MG 60*S(GOFEN) KES 59.13daima_biashara_price_list
TRIOFEN 400 ZAIN PHARMA LIMITED Tablet Unavailable
07 Provenance

Sources & review state

Primary sourceLocal active-ingredient clinical extract; FDA drug label via OpenFDA/DailyMed; WHO / NSAID SmPC safety consensus (batch 1); Professional class pharmacology (NSAID / analgesic–anti-inflammatory)
Last reviewedNot recorded
EvidenceSource-linked
Open source document ↗

Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.